ENST00000598758.5:n.302+4866A>G
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000598758.5(TGFB1):n.302+4866A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.855 in 152,130 control chromosomes in the GnomAD database, including 56,079 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.86   (  56079   hom.,  cov: 31) 
Consequence
 TGFB1
ENST00000598758.5 intron
ENST00000598758.5 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -0.248  
Publications
29 publications found 
Genes affected
 TGFB1  (HGNC:11766):  (transforming growth factor beta 1) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGFB family members. This encoded protein regulates cell proliferation, differentiation and growth, and can modulate expression and activation of other growth factors including interferon gamma and tumor necrosis factor alpha. This gene is frequently upregulated in tumor cells, and mutations in this gene result in Camurati-Engelmann disease. [provided by RefSeq, Aug 2016] 
TGFB1 Gene-Disease associations (from GenCC):
- Camurati-Engelmann diseaseInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
 - inflammatory bowel disease, immunodeficiency, and encephalopathyInheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
 - cystic fibrosisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93). 
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.957  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| TGFB1 | ENST00000598758.5  | n.302+4866A>G | intron_variant | Intron 2 of 3 | 5 | 
Frequencies
GnomAD3 genomes   AF:  0.855  AC: 129993AN: 152012Hom.:  56016  Cov.: 31 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
129993
AN: 
152012
Hom.: 
Cov.: 
31
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome   AF:  0.855  AC: 130118AN: 152130Hom.:  56079  Cov.: 31 AF XY:  0.855  AC XY: 63593AN XY: 74340 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
130118
AN: 
152130
Hom.: 
Cov.: 
31
 AF XY: 
AC XY: 
63593
AN XY: 
74340
show subpopulations 
African (AFR) 
 AF: 
AC: 
40072
AN: 
41534
American (AMR) 
 AF: 
AC: 
12865
AN: 
15276
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
2617
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
4416
AN: 
5158
South Asian (SAS) 
 AF: 
AC: 
4318
AN: 
4820
European-Finnish (FIN) 
 AF: 
AC: 
8627
AN: 
10566
Middle Eastern (MID) 
 AF: 
AC: 
210
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
54411
AN: 
67984
Other (OTH) 
 AF: 
AC: 
1771
AN: 
2116
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.507 
Heterozygous variant carriers
 0 
 936 
 1872 
 2808 
 3744 
 4680 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 886 
 1772 
 2658 
 3544 
 4430 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
3127
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
 RBP_binding_hub_radar 
 RBP_regulation_power_radar 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.